What is WIPO ST.26 and how does it differ from WIPO ST.25?
WIPO ST.26 is a new standard for the presentation of nucleotide and amino acid sequence listings in patent applications. It replaces WIPO ST.25 for applications filed on or after July 1, 2022. The MPEP states: “See MPEP ยงยง 2412 – 2419 for guidance on WIPO ST.26 requirements for applications filed on or after July 1,…
Read MoreWhat are the requirements for content of a “Sequence Listing” part of the specification under WIPO ST.25?
The requirements for the content of a “Sequence Listing” part of the specification under WIPO ST.25 are outlined in 37 CFR 1.823. However, it’s important to note that these requirements are not applicable to all patent applications. As stated in the MPEP: “[Editor Note: This section is not applicable to applications filed on or after…
Read MoreWhen did the requirements for Sequence Listings change?
The requirements for Sequence Listings in patent applications changed on July 1, 2022. This is clearly stated in the MPEP: “[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” For applications filed before July…
Read More